Cancer
Cellular signaling, immune recognition, and microenvironmental factors, studied to understand how cancers begin, progress, and respond to therapy.
- Tumor immunology
- Cell-based therapeutics
- Early cellular signatures

MRK Foundation supports investigators studying the cell as the fundamental unit of biology, where disease begins and where the most durable answers are likely to be found.
Every major field of medicine, including oncology, immunology, cardiology, neurology, gastroenterology, and the biology of aging, ultimately depends on what happens inside and between cells. Studying these systems carefully, in the clinic and in the laboratory, is where we believe the most meaningful progress will come from.
The areas of research we support are chosen because the underlying biology matters, and because rigorous work in these fields has the potential to change how future generations understand and manage disease.
Cellular signaling, immune recognition, and microenvironmental factors, studied to understand how cancers begin, progress, and respond to therapy.
How immune tolerance is built, maintained, and lost, and which cellular mechanisms can help restore balance.
The heart as a cellular system, studied through cardiomyocyte biology, vascular signaling, and the repair mechanisms that follow injury.
Neuronal and glial biology, neuroinflammation, and the cellular processes that underlie cognitive decline and neurodegenerative disease.
Peripheral nerve integrity, myelin biology, and the neuromuscular junction, examined where signaling between nerve and muscle is lost or restored.
The microbiome, mucosal immunity, and the intestinal barrier, examined as regulators of both digestive and systemic health.
Cellular aging, senescence, and metabolic resilience, and the systems that sustain long-term human health.
Stem cell biology, tissue repair, and regenerative strategies that work with the body's own repair systems.
Computational modeling and AI-guided analysis, used to interpret complex cellular data and inform the design of advanced therapies.
We collaborate with investigators, laboratories, and institutions whose work aligns with our focus on advanced gene and cell therapy. Researchers interested in a possible collaboration are welcome to write to us; we read every inquiry and respond thoughtfully.